FDA Inspection 1317258 — University Of Texas Southwestern Medical Center, The
The FDA completed an inspection of University Of Texas Southwestern Medical Center, The on May 15, 2026 in Dallas, TX. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 1 citation was issued during this inspection. Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- May 15, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Dallas, TX (United States)
Citations
| ID | CFR | Description |
|---|---|---|
| 17939 | 21 CFR 212.71(a) | Procedures to Investigate Cause of Non-Conforming Product |